Javier Martinez-Trufero, MD

Medical Oncologist
HU Miguel Servet
Zaragoza, Aragon, Spain

Disclosure information not submitted.

Presentation(s):

• Paper 32 - IMMUNOSARC II MASTER TRIAL (PHASE II OF SUNITINIB AND NIVOLUMAB): RESULTS FROM THE VASCULAR SARCOMAS COHORT. A GEIS, ISG AND UCL STUDY.

  Friday, November 3, 2023
  9:00 AM – 10:00 AM